3-127604987-C-T

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP6_Very_StrongBP7BA1

The NM_004526.4(MCM2):​c.504C>T​(p.Ile168Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.728 in 1,613,788 control chromosomes in the GnomAD database, including 431,880 homozygotes. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.67 ( 35402 hom., cov: 33)
Exomes 𝑓: 0.73 ( 396478 hom. )

Consequence

MCM2
NM_004526.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.08

Publications

30 publications found
Variant links:
Genes affected
MCM2 (HGNC:6944): (minichromosome maintenance complex component 2) The protein encoded by this gene is one of the highly conserved mini-chromosome maintenance proteins (MCM) that are involved in the initiation of eukaryotic genome replication. The hexameric protein complex formed by MCM proteins is a key component of the pre-replication complex (pre_RC) and may be involved in the formation of replication forks and in the recruitment of other DNA replication related proteins. This protein forms a complex with MCM4, 6, and 7, and has been shown to regulate the helicase activity of the complex. This protein is phosphorylated, and thus regulated by, protein kinases CDC2 and CDC7. Multiple alternatively spliced transcript variants have been found, but the full-length nature of some variants has not been defined. [provided by RefSeq, Oct 2012]
MCM2 Gene-Disease associations (from GenCC):
  • autosomal dominant nonsyndromic hearing loss 70
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP6
Variant 3-127604987-C-T is Benign according to our data. Variant chr3-127604987-C-T is described in ClinVar as Benign. ClinVar VariationId is 508098.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.08 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.752 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MCM2NM_004526.4 linkc.504C>T p.Ile168Ile synonymous_variant Exon 4 of 16 ENST00000265056.12 NP_004517.2 P49736
MCM2XM_024453531.2 linkc.477C>T p.Ile159Ile synonymous_variant Exon 4 of 16 XP_024309299.1
MCM2NR_073375.2 linkn.579C>T non_coding_transcript_exon_variant Exon 4 of 16

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MCM2ENST00000265056.12 linkc.504C>T p.Ile168Ile synonymous_variant Exon 4 of 16 1 NM_004526.4 ENSP00000265056.7 P49736

Frequencies

GnomAD3 genomes
AF:
0.674
AC:
102530
AN:
152018
Hom.:
35397
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.537
Gnomad AMI
AF:
0.619
Gnomad AMR
AF:
0.653
Gnomad ASJ
AF:
0.750
Gnomad EAS
AF:
0.646
Gnomad SAS
AF:
0.567
Gnomad FIN
AF:
0.750
Gnomad MID
AF:
0.728
Gnomad NFE
AF:
0.757
Gnomad OTH
AF:
0.691
GnomAD2 exomes
AF:
0.685
AC:
171734
AN:
250872
AF XY:
0.689
show subpopulations
Gnomad AFR exome
AF:
0.530
Gnomad AMR exome
AF:
0.551
Gnomad ASJ exome
AF:
0.752
Gnomad EAS exome
AF:
0.656
Gnomad FIN exome
AF:
0.745
Gnomad NFE exome
AF:
0.762
Gnomad OTH exome
AF:
0.716
GnomAD4 exome
AF:
0.734
AC:
1072127
AN:
1461652
Hom.:
396478
Cov.:
85
AF XY:
0.730
AC XY:
531130
AN XY:
727114
show subpopulations
African (AFR)
AF:
0.525
AC:
17575
AN:
33480
American (AMR)
AF:
0.564
AC:
25199
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.745
AC:
19474
AN:
26132
East Asian (EAS)
AF:
0.657
AC:
26081
AN:
39698
South Asian (SAS)
AF:
0.581
AC:
50099
AN:
86256
European-Finnish (FIN)
AF:
0.747
AC:
39855
AN:
53344
Middle Eastern (MID)
AF:
0.744
AC:
4294
AN:
5768
European-Non Finnish (NFE)
AF:
0.761
AC:
846116
AN:
1111890
Other (OTH)
AF:
0.719
AC:
43434
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
19469
38937
58406
77874
97343
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20274
40548
60822
81096
101370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.674
AC:
102565
AN:
152136
Hom.:
35402
Cov.:
33
AF XY:
0.671
AC XY:
49940
AN XY:
74380
show subpopulations
African (AFR)
AF:
0.536
AC:
22238
AN:
41482
American (AMR)
AF:
0.652
AC:
9978
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.750
AC:
2602
AN:
3470
East Asian (EAS)
AF:
0.647
AC:
3339
AN:
5164
South Asian (SAS)
AF:
0.568
AC:
2741
AN:
4824
European-Finnish (FIN)
AF:
0.750
AC:
7940
AN:
10588
Middle Eastern (MID)
AF:
0.728
AC:
214
AN:
294
European-Non Finnish (NFE)
AF:
0.757
AC:
51498
AN:
67992
Other (OTH)
AF:
0.687
AC:
1452
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1650
3300
4950
6600
8250
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
812
1624
2436
3248
4060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.723
Hom.:
123509
Bravo
AF:
0.661
Asia WGS
AF:
0.611
AC:
2125
AN:
3478
EpiCase
AF:
0.767
EpiControl
AF:
0.770

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
May 09, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Autosomal dominant nonsyndromic hearing loss 70 Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.48
CADD
Benign
3.3
DANN
Benign
0.92
PhyloP100
-1.1
PromoterAI
-0.026
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs893293; hg19: chr3-127323830; COSMIC: COSV54035954; COSMIC: COSV54035954; API